Source: Annual Congress 2013 –New drugs in respiratory medicine
Disease area: Airway diseases



Rating:

Share or cite this content

Citations should be made in the following way:
K. Darwiche, P. Zarogoulidis, C. Ritzoulis, W. Hohenforst-schmidt, L. Sakkas, A. Cheva, A. Sakkas, D. Spyratos, D. Sparopoulou, K. Zarogoulidis (Essen, Coburg, Germany; Thessaloniki, Greece). DEAE-dextran MMA copolymer non-viral vector for aerosol therapy in respiratory diseases. Eur Respir J 2013; 42: Suppl. 57, 1599

Member's Comments

No comment yet.

Related content which might interest you: Development of a novel nano-sized carrier system for aeroseol drug delivery (EGE University translational pulmonology research group) Source: International Congress 2015 – New targets and modalities for the treatment of asthma and COPD Year: 2015 Anti-IgE as an alternative treatment for occupational asthma due to low molecular weight agents Source: International Congress 2016 – Occupational and environmental exposures and biomarkers: human studies, animal data, and in vitro methods Year: 2016 Effect of diminazene on monocrotalin-induced pulmonary hypertension rat model Source: International Congress 2015 – Pulmonary hypertension: novel insights into the biology of the disease Year: 2015 Developing a chronic murine model that better reflects the clinical features of the human asthma Source: International Congress 2016 – Pharmacological intervention in humans and murine models of asthma Year: 2016 Intratracheal administration of dry powdered low-molecular-weight chitosan/siRNA complexes suppressed gene expression in the airway, alveoli, and metastatic tumors in murine lung Source: Annual Congress 2013 –New drugs in respiratory medicine Year: 2013 Characterisation of an experimental mouse model of exposure to nanoparticles. Relevance to human sarcoidosis Source: International Congress 2015 – Sarcoidosis: clinical Year: 2015 Animal models in drug development Source: Research Seminar 2013 - Optimising models for human lung diseases and drug development Year: 2013 Deposition and pulmonary effect of nanoparticle in whole body inhalation study and in nose only inhalation study Source: International Congress 2015 – Occupational and environmental effects: in vitro and animal models Year: 2015 Mesoporous silica-based nanoparticles for targeted delivery of proteasome inhibitors to the lung Source: Annual Congress 2013 –Cutting edge: drug delivery to the airways Year: 2013 Effects of tobacco smoke and poly IC, alone and in combination, on mouse lung pathology Source: Annual Congress 2013 –Preclinical models for the development of new drugs for respiratory diseases Year: 2013 RIG-I receptors induced by dsRNA challenges in an HDM-mouse model of asthma exacerbation Source: International Congress 2014 – Exploring molecular mechanisms of allergy and asthma in animal models Year: 2014 Engineered gold nanoparticles targeted to mesenchymal cells from BOS patients can be safely administered to normal mice by inhalation Source: International Congress 2015 – Pathogenic mechanisms of lung transplant complications: a focus on CLAD Year: 2015 Simulation of particle deposition in the human airways Source: Annual Congress 2013 –Airway calibre, airway challenge and assessment of oxygenation Year: 2013 Biodistribution of engineered hematite nanoparticles in healthy and asthmatic mice Source: Annual Congress 2013 –Environmental and occupational respiratory diseases: new exposure assessment methods, experimental exposure in animal and humans and mechanisms Year: 2013 Development of a lung slice methodology to study the mechanisms of lung uptake and lysosomal trapping Source: International Congress 2014 – Novel approaches and evidence for drug development in respiratory diseases Year: 2014 Mepenzolate bromide displays beneficial effects in a mouse model of chronic obstructive pulmonary disease Source: International Congress 2014 – Animal models in respiratory drug development Year: 2014 A new model for analysis of chronic bronchial interleukin-8 expression Source: International Congress 2016 – Airway response to infection Year: 2016 Respiratory consequences of fluid replacement with autologous blood or colloid solution after acute haemorrhage in rats Source: Annual Congress 2013 –Clinical physiology and functional imaging in health and disease Year: 2013 Pre-clinical to clinical potency of AZD7624 in LPS induced TNFa response Source: International Congress 2015 – New targets and modalities for the treatment of asthma and COPD Year: 2015